Status:
NOT_YET_RECRUITING
Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Hiv
Syphilis
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
This study aims to validate the percent agreement of the INSTI Multiplex Human Immunodeficiency (HIV) 1/2 syphilis antibody (Ab) test (INSTI POCT) when used as a self-test by patients compared to conv...
Eligibility Criteria
Inclusion
- Branch #1: Participants known to have an HIV infection - Inclusion criteria:
- • Previously documented positive HIV serology
- Branch #2: Participants known to have a history of syphilis infection - Inclusion criteria:
- • Documented positive syphilis serology
- Branch #3: Participants with no known HIV or syphilis infections - Inclusion criteria:
- • No documented positive HIV or syphilis serology
- Exclusion criteria:
- Unable to speak and understand English
Exclusion
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06953024
Start Date
June 1 2025
End Date
December 1 2026
Last Update
May 1 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.